16d
Medical Device Network on MSNFDA grants EUA to Aptitude’s Covid/flu multiplex test for OTC useIn partnership with Sekisui Diagnostics, the company and its distribution partners have made the test available across the US.
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
after review of both Pfizer’s and Moderna’s EUA requests, the FDA concluded that the requests do not raise questions that would benefit from additional discussion by committee members." ...
was declined by the U.S. Food and Drug Administration. Existing PEMGARDA EUA for pre-exposure prophylaxis of COVID-19 in certain immunocompromised patients remains in effect. “This is a sad day ...
(RTTNews) - Invivyd, Inc. (IVVD), a biopharmaceutical company, on Monday announced the submission of an updated immunobridging analysis to the U.S. Food and Drug Administration or FDA in support ...
Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. Dear Reader, Blood purification technologies have emerged to become ...
February 18, 2025--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration ... Emergency Use Authorization (EUA) status in May 2020.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results